1. Home
  2. TECX vs NGL Comparison

TECX vs NGL Comparison

Compare TECX & NGL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Tectonic Therapeutic Inc.

TECX

Tectonic Therapeutic Inc.

HOLD

Current Price

$21.31

Market Cap

359.0M

Sector

N/A

ML Signal

HOLD

Logo NGL ENERGY PARTNERS LP

NGL

NGL ENERGY PARTNERS LP

BUY

Current Price

$9.97

Market Cap

751.7M

Sector

Utilities

ML Signal

BUY

Company Overview

Basic Information
Metric
TECX
NGL
Founded
2019
1940
Country
United States
United States
Employees
N/A
N/A
Industry
Natural Gas Distribution
Sector
Utilities
Exchange
Nasdaq
Nasdaq
Market Cap
359.0M
751.7M
IPO Year
2018
2011

Fundamental Metrics

Financial Performance
Metric
TECX
NGL
Price
$21.31
$9.97
Analyst Decision
Strong Buy
Analyst Count
5
0
Target Price
$81.20
N/A
AVG Volume (30 Days)
319.1K
254.7K
Earning Date
11-06-2025
02-09-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
N/A
$3,250,313,000.00
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
N/A
N/A
Revenue Growth
N/A
46.95
52 Week Low
$13.70
$2.64
52 Week High
$61.07
$10.29

Technical Indicators

Market Signals
Indicator
TECX
NGL
Relative Strength Index (RSI) 56.48 56.42
Support Level $20.54 $9.85
Resistance Level $22.00 $10.18
Average True Range (ATR) 1.10 0.33
MACD 0.09 -0.04
Stochastic Oscillator 77.67 74.63

Price Performance

Historical Comparison
TECX
NGL

About TECX Tectonic Therapeutic Inc.

Tectonic Therapeutic Inc is a biotechnology company focused on the discovery and development of therapeutic proteins and antibodies that modulate the activity of GPCRs. Its technology platform called GEODe, Tectonic is focused on developing biologic medicines that overcome the existing challenges of GPCR-targeted drug discovery to modify the course of disease. Company focus on areas of important unmet medical need, often where therapeutic options are poor or nonexistent, and where new medicines have the potential to improve patient quality of life or extend duration of life. Pipeline includes TX000045, Group 2 PH, TX2100: GPCR Antagonist for Hereditary Hemorrhagic Telangiectasia (HHT), Fibrosis.

About NGL NGL ENERGY PARTNERS LP

NGL Energy Partners LP is a USA-based firm that owns and operates a vertically integrated energy business. The company's operating segments include Crude Oil Logistics, Water Solutions, and Liquids Logistics. It operates crude oil Logistics, owns pipeline injection stations, and offers services for the treatment and disposal of wastewater generated from crude oil and natural gas production, as well as for the disposal of solids, such as tank bottoms and drilling fluids. The firm also supplies natural gas liquids to retailers, wholesalers, refiners, and petrochemical plants and sells propane and distillates.

Share on Social Networks: